Literature DB >> 11126282

Amiodarone-induced pulmonary interstitial fibrosis.

A Iliopoulou, H Pagou, G Giannakopoulos, T Spiropoulos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11126282     DOI： 10.1007/s001340000657

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  [Lung changes in amiodarone therapy].

Authors:  L Prayer; P Hübsch; H Frank
Journal:  Pneumologie       Date:  1989-11

2.  Long-term low-dose amiodarone therapy in the management of ventricular and supraventricular tachyarrhythmias: efficacy and safety.

Authors:  K L Lee; Y T Tai
Journal:  Clin Cardiol       Date:  1997-04       Impact factor: 2.882

3.  Pulmonary effect of amiodarone in patients with heart failure. The Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy (CHF-STAT) Investigators (Veterans Affairs Cooperative Study No. 320).

Authors:  S N Singh; S G Fisher; P C Deedwania; P Rohatgi; B N Singh; R D Fletcher
Journal:  J Am Coll Cardiol       Date:  1997-08       Impact factor: 24.094

4.  Spontaneous regression of amiodarone pulmonary toxicity.

Authors:  P Fraioli; M Barberis; L Montemurro
Journal:  Sarcoidosis       Date:  1990-03

5.  [Recurrent alveolitis caused by amiodarone].

Authors:  S Scardi; F Ciani; C Pandullo; R Padrini; F Pivotti
Journal:  G Ital Cardiol       Date:  1986-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.